**Author details**

Siddharth Sharma1 , Kimberley Oliver2 and David W Mudge1


[12] Loupy, A., et al., Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Trans‐

Advances in Antibody Mediated Rejection http://dx.doi.org/10.5772/54855 459

[13] Einecke, G., et al., Antibody-mediated microcirculation injury is the major cause of late

[14] Hidalgo, L.G., et al., De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant,

[15] Gaston, R.S., et al., Evidence for antibody-mediated injury as a major determinant of

[16] Sellares, J., et al., Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant, 2012. 12(2):

[17] Kissmeyer-Nielsen, F., et al., Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet, 1966. 2(7465): p. 662-5. [18] Halloran, P.F., et al., The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation,

[19] Montgomery, R.A., et al., Desensitization in HLA-incompatible kidney recipients and

[20] Lefaucheur, C., et al., Clinical relevance of preformed HLA donor-specific antibodies

[21] Smith, R.N. and R.B. Colvin, Chronic alloantibody mediated rejection. Semin Immunol,

[22] Jordan, S.C., M. Toyoda, and A.A. Vo, Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev

[24] Jordan, S.C., et al., B-cell immunotherapeutics: emerging roles in solid organ trans‐

[25] Loupy, A., et al., Combined posttransplant prophylactic IVIg/anti-CD 20/plasmaphe‐ resis in kidney recipients with preformed donor-specific antibodies: a pilot study.

[26] Haas, M., et al., Subclinical acute antibody-mediated rejection in positive crossmatch

[27] Lerut, E., et al., Subclinical peritubular capillaritis at 3 months is associated with chronic

[23] Platt, J.L., Antibodies in transplantation. Discov Med, 2010. 10(51): p. 125-33.

plantation. Curr Opin Organ Transplant, 2011. 16(4): p. 416-24.

renal allografts. Am J Transplant, 2007. 7(3): p. 576-85.

rejection at 1 year. Transplantation, 2007. 83(11): p. 1416-22.

kidney transplant failure. Am J Transplant, 2009. 9(11): p. 2520-31.

late kidney allograft failure. Transplantation, 2010. 90(1): p. 68-74.

plant, 2011. 11(1): p. 56-65.

2009. 9(11): p. 2532-41.

1992. 53(3): p. 550-5.

2012. 24(2): p. 115-21.

Clin Immunol, 2011. 7(3): p. 341-8.

Transplantation, 2010. 89(11): p. 1403-10.

survival. N Engl J Med, 2011. 365(4): p. 318-26.

in kidney transplantation. Contrib Nephrol, 2009. 162: p. 1-12.

p. 388-99.
